AnaptysBio Inc (NASDAQ: ANAB) is 8.46% higher on its value in year-to-date trading and has touched a low of $12.51 and a high of $41.31 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ANAB stock was last observed hovering at around $14.83 in the last trading session, with the day’s loss setting it -0.47%.
Currently trading at $14.36, the stock is -4.36% and -26.70% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.46 million and changing -3.17% at the moment leaves the stock -46.44% off its SMA200. ANAB registered -36.38% loss for a year compared to 6-month loss of -47.38%. The firm has a 50-day simple moving average (SMA 50) of $19.9446 and a 200-day simple moving average (SMA200) of $26.84945.
The stock witnessed a -42.12% gain in the last 1 month and extending the period to 3 months gives it a -55.61%, and is 8.46% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.78% over the week and 8.79% over the month.
AnaptysBio Inc (ANAB) has around 117 employees, a market worth around $436.96M and $57.17M in sales. Profit margin for the company is -289.75%. Distance from 52-week low is 14.79% and -65.24% from its 52-week high. The company has generated returns on investments over the last 12 months (-36.85%).
The EPS is expected to shrink by -0.07% this year
229.0 institutions hold shares in AnaptysBio Inc (ANAB), with institutional investors hold 119.40% of the company’s shares. The shares outstanding are 30.43M, and float is at 26.01M with Short Float at 26.86%. Institutions hold 117.33% of the Float.
The top institutional shareholder in the company is ECOR1 CAPITAL, LLC with over 7.52 million shares valued at $188.48 million. The investor’s holdings represent 27.4931 of the ANAB Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 2.87 million shares valued at $71.94 million to account for 10.4936 of the shares outstanding. The other top investors are FRAZIER LIFE SCIENCES MANAGEMENT, L.P. which holds 2.17 million shares representing 7.9163 and valued at over $54.27 million, while BLACKROCK INC. holds 6.47 of the shares totaling 1.77 million with a market value of $44.35 million.
AnaptysBio Inc (ANAB) Insider Activity
The most recent transaction is an insider purchase by EcoR1 Capital, LLC, the company’s Director. SEC filings show that EcoR1 Capital, LLC bought 65,184 shares of the company’s common stock on Dec 30 ’24 at a price of $12.92 per share for a total of $0.84 million. Following the purchase, the insider now owns 7.86 million shares.
AnaptysBio Inc disclosed in a document filed with the SEC on Dec 31 ’24 that EcoR1 Capital, LLC (Director) bought a total of 13,268 shares of the company’s common stock. The trade occurred on Dec 31 ’24 and was made at $12.93 per share for $0.17 million. Following the transaction, the insider now directly holds 7.87 million shares of the ANAB stock.
Still, SEC filings show that on Jan 02 ’25, EcoR1 Capital, LLC (Director) acquired 6,646 shares at an average price of $12.95 for $86070.0. The insider now directly holds 7,880,094 shares of AnaptysBio Inc (ANAB).
